Login / Signup

Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL.

Jonathan C AlsopJennie MedinChristian CornelissenStefan Viktor VormfeldeTjalf Ziemssen
Published in: PloS one (2017)
Fingolimod appears to be more effective than BRACE in improving clinical and physician-/patient-reported outcomes in individuals with active MS.
Keyphrases
  • multiple sclerosis
  • patient reported outcomes
  • case control
  • emergency department
  • primary care
  • mass spectrometry
  • electronic health record
  • ms ms
  • data analysis
  • deep learning